报价延迟最少15分钟:2025/07/19 03:41 EDT
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
5.69 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
0.24/--
|
|
企业价值
282.99M
|
| 资产负债 |
|
每股账面净值
0.84
|
| 现金流量 |
|
现金流量率
0.02
|
| 损益表 |
|
收益
186.36M
|
|
每股收益
--
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟：2025/07/19 03:41 EDT
同行比较之报价最少15分钟延迟
|
业务概览
|
|||
| Zhengye Biotechnology Holding Ltd is engaged in research, development, manufacturing, and sales of veterinary vaccines, with an emphasis on vaccines for livestock. It has a diverse range of vaccines, including vaccines for swine, cattle, goats, waterfowl, sheep, poultry, and pets, available in various provincial regions across China and are exported overseas to Vietnam, Pakistan, and Egypt. The company generates maximum revenue from the sale of swine vaccines, followed by poultry, and other vaccines. |
